GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lumiera Health Inc (TSXV:NHP.H) » Definitions » EV-to-Revenue

Lumiera Health (TSXV:NHP.H) EV-to-Revenue : 5.82 (As of May. 28, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Lumiera Health EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Lumiera Health's enterprise value is C$2.52 Mil. Lumiera Health's Revenue for the trailing twelve months (TTM) ended in Aug. 2023 was C$0.43 Mil. Therefore, Lumiera Health's EV-to-Revenue for today is 5.82.

The historical rank and industry rank for Lumiera Health's EV-to-Revenue or its related term are showing as below:

TSXV:NHP.H' s EV-to-Revenue Range Over the Past 10 Years
Min: 4   Med: 7.08   Max: 134.46
Current: 5.82

During the past 10 years, the highest EV-to-Revenue of Lumiera Health was 134.46. The lowest was 4.00. And the median was 7.08.

TSXV:NHP.H's EV-to-Revenue is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.3 vs TSXV:NHP.H: 5.82

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-28), Lumiera Health's stock price is C$0.005. Lumiera Health's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 was C$0.00. Therefore, Lumiera Health's PS Ratio for today is 2.50.


Lumiera Health EV-to-Revenue Historical Data

The historical data trend for Lumiera Health's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumiera Health EV-to-Revenue Chart

Lumiera Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Nov18 Nov19 Nov20 Nov21 Nov22
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.15 19.40 8.82 5.51 4.33

Lumiera Health Quarterly Data
Sep18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.38 4.33 4.00 4.95 4.98

Competitive Comparison of Lumiera Health's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Lumiera Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumiera Health's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lumiera Health's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lumiera Health's EV-to-Revenue falls into.



Lumiera Health EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Lumiera Health's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2.518/0.433
=5.82

Lumiera Health's current Enterprise Value is C$2.52 Mil.
Lumiera Health's Revenue for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.43 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumiera Health  (TSXV:NHP.H) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Lumiera Health's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.005/0.002
=2.50

Lumiera Health's share price for today is C$0.005.
Lumiera Health's Revenue per Share for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumiera Health EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lumiera Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumiera Health (TSXV:NHP.H) Business Description

Traded in Other Exchanges
N/A
Address
4500 Kimber, Suite 26, Saint-Hubert, QC, CAN, J3Y 8K5
Lumiera Health Inc is a natural health products company. The company is developing products focusing on the endocannabinoid system and providing treatments for chronic pain and inflammation.

Lumiera Health (TSXV:NHP.H) Headlines

No Headlines